PRAMIPEXOLE

PRAMIPEXOLE was reported 15657 times

PRAMIPEXOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RESTLESS LEG AUGMENTATION SYNDROME 78 0.5032
1 DOPAMINE AGONIST WITHDRAWAL SYNDROME 25 0.4630
2 PARKINSONISM HYPERPYREXIA SYNDROME 45 0.2514
3 ENCEPHALITIS TOXIC 17 0.2152
4 GAIT SPASTIC 57 0.1662
5 PARAPHILIA 17 0.1308
6 DOPAMINE DYSREGULATION SYNDROME 56 0.1256
7 NEEDLE FATIGUE 56 0.1225
8 RESTLESS ARM SYNDROME 19 0.1218
9 JEALOUS DELUSION 33 0.1166
10 IMPULSE-CONTROL DISORDER 201 0.0976
11 CAMPTOCORMIA 22 0.0917
12 DELUSION OF PARASITOSIS 14 0.0892
13 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 81 0.0874
14 ANTACID THERAPY 11 0.0846
15 CONGENITAL HIATUS HERNIA 19 0.0833
16 RELAPSING-REMITTING MULTIPLE SCLEROSIS 62 0.0718
17 ON AND OFF PHENOMENON 390 0.0702
18 FREEZING PHENOMENON 254 0.0685
19 MALIGNANT POLYP 13 0.0684
20 GRANULOMA SKIN 55 0.0670
21 HYPERSEXUALITY 119 0.0651
22 STEREOTYPY 47 0.0498
23 PLEUROTHOTONUS 45 0.0498
24 STOMA SITE REACTION 34 0.0496
25 STOMA SITE ERYTHEMA 89 0.0476
26 PENIS INJURY 17 0.0472
27 CEREBRAL HYPOPERFUSION 22 0.0472
28 PARKINSONIAN GAIT 28 0.0449
29 DRUG-GENETIC INTERACTION 16 0.0448
30 COMPULSIVE SHOPPING 92 0.0447
31 TOTAL LUNG CAPACITY DECREASED 71 0.0444
32 BINGE EATING 47 0.0436
33 ANTICOAGULANT THERAPY 12 0.0423
34 GAMBLING 49 0.0420
35 GAMBLING DISORDER 113 0.0418
36 EUTHANASIA 13 0.0410
37 REDUCED FACIAL EXPRESSION 41 0.0404
38 BLOOD PARATHYROID HORMONE DECREASED 57 0.0384
39 DRUG THERAPY 13 0.0383
40 DROPPED HEAD SYNDROME 15 0.0380
41 SLEEP ATTACKS 18 0.0378
42 ANALGESIC THERAPY 12 0.0374
43 PNEUMOCOCCAL INFECTION 22 0.0372
44 STOMA SITE DISCHARGE 96 0.0350
45 STOMA SITE HYPERGRANULATION 22 0.0349
46 FIBROMA 31 0.0337
47 PERIODIC LIMB MOVEMENT DISORDER 12 0.0326
48 MONOPARESIS 58 0.0320
49 MULTIPLE DRUG THERAPY 24 0.0318
50 HALLUCINATION, TACTILE 21 0.0315
51 STOMA SITE IRRITATION 17 0.0312
52 SUSPICIOUSNESS 21 0.0299
53 HYPERKINESIA 63 0.0297
54 STOMA SITE PAIN 42 0.0286
55 PATHOLOGICAL GAMBLING 47 0.0283
56 BRADYKINESIA 161 0.0272
57 COMPULSIONS 18 0.0270
58 STOMA SITE INFECTION 35 0.0269
59 DEEP BRAIN STIMULATION 16 0.0265
60 ORTHOSTATIC INTOLERANCE 19 0.0265
61 LUNG OPACITY 69 0.0262
62 RESTLESS LEGS SYNDROME 464 0.0255
63 STOMA SITE INFLAMMATION 19 0.0254
64 RESTING TREMOR 16 0.0248
65 PANNICULITIS 57 0.0235
66 HYPERTONIC BLADDER 64 0.0221
67 RHEUMATOID NODULE 57 0.0207
68 AKINESIA 40 0.0193
69 LIBIDO INCREASED 39 0.0192
70 SKIN NEOPLASM EXCISION 15 0.0192
71 PLEURITIC PAIN 51 0.0185
72 MUSCLE RIGIDITY 212 0.0177
73 DYSKINESIA 717 0.0176
74 DELUSIONAL DISORDER, UNSPECIFIED TYPE 13 0.0174
75 THERAPEUTIC PRODUCT EFFECT VARIABLE 67 0.0173
76 ACUTE PSYCHOSIS 40 0.0162
77 IMPULSIVE BEHAVIOUR 60 0.0160
78 STOMA SITE HAEMORRHAGE 24 0.0156
79 DRUG TOLERANCE DECREASED 43 0.0153
80 BREATH SOUNDS ABNORMAL 75 0.0152
81 DEVICE LOOSENING 13 0.0150
82 HALLUCINATION, VISUAL 313 0.0148
83 UTERINE PROLAPSE 16 0.0147
84 TORTICOLLIS 29 0.0137
85 DRUG EFFECT VARIABLE 15 0.0132
86 SUDDEN ONSET OF SLEEP 18 0.0130
87 NEOPLASM SKIN 20 0.0129
88 STOMA COMPLICATION 13 0.0128
89 DEVICE ALARM ISSUE 23 0.0127
90 DRUG DISPENSED TO WRONG PATIENT 12 0.0126
91 INFUSION SITE NODULE 12 0.0125
92 DEVICE CONNECTION ISSUE 26 0.0123
93 RALES 71 0.0122
94 CHRONIC FATIGUE SYNDROME 17 0.0122
95 CHOREA 21 0.0122
96 RHEUMATOID FACTOR POSITIVE 70 0.0121
97 NOCTURIA 143 0.0118
98 BRONCHIECTASIS 79 0.0117
99 BLOOD PRESSURE DIASTOLIC ABNORMAL 29 0.0114
100 SKIN NECROSIS 59 0.0114
101 HALLUCINATION 838 0.0111
102 POSTURE ABNORMAL 36 0.0111
103 HALLUCINATIONS, MIXED 46 0.0109
104 CATAPLEXY 15 0.0106
105 OBSTRUCTIVE SLEEP APNOEA SYNDROME 15 0.0103
106 DELUSION 156 0.0100
107 SPUTUM DISCOLOURED 94 0.0099
108 DEMENTIA WITH LEWY BODIES 11 0.0099
109 ASPIRATION 106 0.0097
110 PRE-EXISTING CONDITION IMPROVED 60 0.0096
111 PERIPHERAL SENSORIMOTOR NEUROPATHY 12 0.0095
112 PRODUCT RESIDUE PRESENT 51 0.0094
113 TINEA PEDIS 15 0.0094
114 BLOOD CALCIUM INCREASED 82 0.0093
115 SPINAL STENOSIS 38 0.0092
116 DYSTONIA 177 0.0091
117 SINUS PAIN 21 0.0090
118 FINE MOTOR SKILL DYSFUNCTION 26 0.0090
119 OBSESSIVE-COMPULSIVE DISORDER 72 0.0090
120 MICTURITION URGENCY 100 0.0087
121 TENSION 53 0.0087
122 PULMONARY FIBROSIS 163 0.0085
123 ADJUSTMENT DISORDER 11 0.0085
124 ABNORMAL SLEEP-RELATED EVENT 11 0.0083
125 BIPOLAR I DISORDER 18 0.0082
126 PARKINSONISM 79 0.0081
127 MUSCLE SPASTICITY 98 0.0080
128 FOOD INTERACTION 14 0.0079
129 OBSESSIVE THOUGHTS 14 0.0078
130 SLEEP TALKING 13 0.0077
131 DEPRESSIVE SYMPTOM 27 0.0077
132 ANTICHOLINERGIC SYNDROME 12 0.0075
133 NEUROLEPTIC MALIGNANT SYNDROME 88 0.0074
134 BRADYPNOEA 20 0.0074
135 RED BLOOD CELL SEDIMENTATION RATE INCREASED 81 0.0073
136 ILLUSION 12 0.0073
137 CLOSTRIDIUM TEST POSITIVE 16 0.0072
138 TROPONIN INCREASED 55 0.0072
139 VAGINAL INFECTION 34 0.0072
140 PERSECUTORY DELUSION 18 0.0072
141 SKIN ABRASION 34 0.0072
142 HYPERPARATHYROIDISM SECONDARY 18 0.0072
143 YAWNING 19 0.0071
144 HYPOMANIA 26 0.0071
145 SEDATION COMPLICATION 18 0.0070
146 SLEEP APNOEA SYNDROME 133 0.0070
147 HYPERPHAGIA 27 0.0068
148 ATAXIA 80 0.0067
149 ORTHOSTATIC HYPOTENSION 116 0.0067
150 OBSTRUCTIVE AIRWAYS DISORDER 73 0.0066
151 SOMNAMBULISM 43 0.0065
152 BLOOD TEST ABNORMAL 92 0.0065
153 NONSPECIFIC REACTION 35 0.0064
154 BEHAVIOUR DISORDER 33 0.0061
155 WHEELCHAIR USER 27 0.0061
156 INFUSION SITE BRUISING 13 0.0060
157 BLOOD PRESSURE INADEQUATELY CONTROLLED 36 0.0060
158 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 61 0.0059
159 ATTENTION DEFICIT HYPERACTIVITY DISORDER 25 0.0059
160 DRUG TOLERANCE 30 0.0059
161 DYSCHEZIA 18 0.0059
162 MOTOR DYSFUNCTION 59 0.0058
163 LISTLESS 19 0.0058
164 THERAPEUTIC PRODUCT EFFECT DELAYED 26 0.0057
165 REHABILITATION THERAPY 22 0.0057
166 SLEEP DEFICIT 12 0.0057
167 HYPERCALCAEMIA 69 0.0056
168 COMA SCALE ABNORMAL 16 0.0055
169 PRODUCT ADMINISTRATION INTERRUPTED 43 0.0055
170 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
171 NEPHROGENIC ANAEMIA 25 0.0054
172 LOGORRHOEA 19 0.0054
173 EXERCISE TOLERANCE DECREASED 31 0.0054
174 CARDIAC DYSFUNCTION 20 0.0054
175 PULMONARY MASS 80 0.0054
176 HYPERCAPNIA 16 0.0053
177 IMMOBILE 23 0.0053
178 BLOOD PRESSURE SYSTOLIC ABNORMAL 13 0.0053
179 WOUND COMPLICATION 18 0.0052
180 HYPOKINESIA 75 0.0052
181 POOR QUALITY SLEEP 111 0.0052
182 SKIN LACERATION 56 0.0051
183 PSYCHOTIC DISORDER 149 0.0050
184 CENTRAL NERVOUS SYSTEM LESION 69 0.0050
185 DEVICE KINK 18 0.0049
186 CERVICAL VERTEBRAL FRACTURE 17 0.0049
187 ULCER 78 0.0049
188 THERAPEUTIC RESPONSE SHORTENED 162 0.0049
189 HYPERVENTILATION 28 0.0048
190 HYDRONEPHROSIS 36 0.0048
191 BASAL CELL CARCINOMA 75 0.0048
192 MOVEMENT DISORDER 153 0.0048
193 PRESCRIBED UNDERDOSE 95 0.0048
194 TENOSYNOVITIS 13 0.0047
195 DELIRIUM 163 0.0047
196 CATHETER SITE PAIN 12 0.0046
197 PSYCHOMOTOR SKILLS IMPAIRED 12 0.0046
198 BALANCE DISORDER 389 0.0045
199 DEVICE OCCLUSION 63 0.0045
200 BLOOD PRESSURE DIASTOLIC DECREASED 33 0.0045
201 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 213 0.0044
202 WALKING AID USER 29 0.0044
203 MIDDLE INSOMNIA 82 0.0044
204 ABNORMAL DREAMS 121 0.0044
205 COGNITIVE DISORDER 204 0.0044
206 TRANSAMINASES INCREASED 97 0.0044
207 INFUSION SITE REACTION 13 0.0043
208 SYNOVITIS 77 0.0043
209 MEDICATION ERROR 235 0.0042
210 COLITIS MICROSCOPIC 20 0.0042
211 RESPIRATORY SYMPTOM 12 0.0042
212 ALCOHOLISM 18 0.0042
213 INITIAL INSOMNIA 43 0.0042
214 PARANOIA 72 0.0042
215 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
216 TOOTH ABSCESS 42 0.0041
217 ALCOHOL ABUSE 11 0.0041
218 SALIVARY HYPERSECRETION 41 0.0041
219 DYSARTHRIA 150 0.0040
220 CHOLECYSTITIS INFECTIVE 11 0.0040
221 LIVER FUNCTION TEST INCREASED 85 0.0040
222 DYSGRAPHIA 26 0.0039
223 MEDICAL DEVICE DISCOMFORT 12 0.0039
224 FEELING OF BODY TEMPERATURE CHANGE 23 0.0039
225 SOPOR 51 0.0038
226 MOBILITY DECREASED 276 0.0038
227 MANIA 63 0.0038
228 FOOD INTOLERANCE 14 0.0038
229 FLUID INTAKE REDUCED 19 0.0038
230 TREMOR 629 0.0038
231 DROOLING 26 0.0038
232 THERAPEUTIC PRODUCT EFFECT DECREASED 168 0.0037
233 INTERVERTEBRAL DISC DISORDER 16 0.0037
234 MUSCULOSKELETAL STIFFNESS 328 0.0037
235 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
236 ARTHRITIS INFECTIVE 17 0.0037
237 ABNORMAL FAECES 30 0.0037
238 PSYCHIATRIC SYMPTOM 27 0.0037
239 CLAVICLE FRACTURE 14 0.0037
240 SELF-MEDICATION 15 0.0036
241 GAIT DISTURBANCE 691 0.0036
242 FAECES HARD 14 0.0036
243 MUSCLE RUPTURE 14 0.0036
244 PERIPHERAL SENSORY NEUROPATHY 21 0.0036
245 SPEECH DISORDER 188 0.0036
246 RESTLESSNESS 131 0.0036
247 NERVE COMPRESSION 33 0.0036
248 PERONEAL NERVE PALSY 20 0.0035
249 ROTATOR CUFF SYNDROME 45 0.0035
250 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
251 FALL 1160 0.0035
252 DEMENTIA 97 0.0035
253 ENURESIS 14 0.0035
254 BLOOD PRESSURE FLUCTUATION 83 0.0035
255 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 245 0.0034
256 SPINAL OPERATION 42 0.0034
257 HALLUCINATION, AUDITORY 54 0.0034
258 FINGER DEFORMITY 16 0.0033
259 DRUG ERUPTION 58 0.0033
260 ABNORMAL BEHAVIOUR 129 0.0033
261 DYSSTASIA 95 0.0033
262 END STAGE RENAL DISEASE 59 0.0032
263 EMBEDDED DEVICE 32 0.0032
264 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0032
265 PERSONALITY CHANGE 30 0.0032
266 HYPOXIA 113 0.0032
267 PSYCHOMOTOR HYPERACTIVITY 53 0.0032
268 HAEMOPTYSIS 89 0.0032
269 ERYSIPELAS 16 0.0032
270 HYPERTHERMIA 24 0.0031
271 GAIT INABILITY 105 0.0031
272 NEURALGIA 76 0.0031
273 INFUSION SITE ERYTHEMA 26 0.0031
274 MEMORY IMPAIRMENT 423 0.0031
275 HYPERPYREXIA 13 0.0031
276 CARPAL TUNNEL SYNDROME 43 0.0031
277 HYPOTHERMIA 31 0.0031
278 DIABETES MELLITUS INADEQUATE CONTROL 54 0.0030
279 ERECTILE DYSFUNCTION 78 0.0030
280 INCONTINENCE 32 0.0030
281 GENERAL PHYSICAL HEALTH DETERIORATION 349 0.0030
282 INTENTIONAL UNDERDOSE 22 0.0030
283 CEREBRAL ATROPHY 12 0.0030
284 BOWEL MOVEMENT IRREGULARITY 23 0.0030
285 CONFUSIONAL STATE 482 0.0030
286 SKIN ULCER 77 0.0030
287 FRUSTRATION TOLERANCE DECREASED 24 0.0030
288 URINARY INCONTINENCE 88 0.0030
289 JOINT INJURY 63 0.0029
290 HICCUPS 24 0.0029
291 FAECALOMA 16 0.0029
292 SCOLIOSIS 18 0.0029
293 POLLAKIURIA 121 0.0029
294 FOOT DEFORMITY 32 0.0029
295 PNEUMONIA ASPIRATION 72 0.0029
296 MAJOR DEPRESSION 21 0.0029
297 BRADYCARDIA 152 0.0029
298 OEDEMA PERIPHERAL 349 0.0029
299 SOMNOLENCE 574 0.0028
300 DIPLOPIA 74 0.0028
301 LIMB DISCOMFORT 88 0.0028
302 TERMINAL STATE 19 0.0028
303 PERIPHERAL SWELLING 437 0.0028
304 POST-TRAUMATIC STRESS DISORDER 19 0.0028
305 FOOT OPERATION 14 0.0028
306 DECUBITUS ULCER 23 0.0028
307 CONDITION AGGRAVATED 856 0.0028
308 LOCALISED INFECTION 68 0.0028
309 APATHY 41 0.0028
310 DEVICE DISLOCATION 122 0.0028
311 THINKING ABNORMAL 52 0.0028
312 TEARFULNESS 12 0.0028
313 C-REACTIVE PROTEIN INCREASED 101 0.0028
314 SUICIDAL IDEATION 254 0.0028
315 HIP SURGERY 15 0.0028
316 DYSPHORIA 14 0.0028
317 BIPOLAR DISORDER 30 0.0028
318 AGITATION 202 0.0027
319 UPPER RESPIRATORY TRACT INFECTION 127 0.0027
320 LYMPHOEDEMA 19 0.0027
321 GRIP STRENGTH DECREASED 24 0.0027
322 PELVIC FRACTURE 21 0.0027
323 SKIN MASS 18 0.0027
324 LOWER RESPIRATORY TRACT INFECTION 122 0.0027
325 POLYNEUROPATHY 32 0.0027
326 SUICIDE ATTEMPT 162 0.0027
327 CHRONIC KIDNEY DISEASE 203 0.0027
328 INFUSION RELATED REACTION 177 0.0027
329 WRIST FRACTURE 32 0.0027
330 SCREAMING 17 0.0027
331 IRON DEFICIENCY 12 0.0027
332 SLEEP DISORDER 188 0.0027
333 DEPRESSED MOOD 140 0.0026
334 BLOOD CREATININE INCREASED 171 0.0026
335 DISORIENTATION 103 0.0026
336 AGGRESSION 130 0.0026
337 FOOT FRACTURE 49 0.0026
338 BACK DISORDER 42 0.0026
339 MYOSITIS 23 0.0026
340 HEAD INJURY 81 0.0026
341 MENTAL IMPAIRMENT 62 0.0026
342 BRAIN FOG 40 0.0025
343 BLOOD IRON DECREASED 30 0.0025
344 SEDATION 66 0.0025
345 ACUTE PULMONARY OEDEMA 14 0.0025
346 HIP FRACTURE 80 0.0025
347 HYPERCHOLESTEROLAEMIA 24 0.0025
348 HIATUS HERNIA 32 0.0025
349 POLYURIA 20 0.0024
350 ARTHRITIS 192 0.0024
351 MENISCUS INJURY 15 0.0024
352 IMPAIRED QUALITY OF LIFE 35 0.0024
353 HYPONATRAEMIA 137 0.0024
354 MYOCLONUS 29 0.0024
355 ABDOMINAL HERNIA 11 0.0024
356 SKIN INFECTION 27 0.0024
357 OSTEOARTHRITIS 102 0.0024
358 DEVICE USE ISSUE 42 0.0024
359 ADRENAL INSUFFICIENCY 29 0.0024
360 DRUG INTERACTION 379 0.0024
361 HYPOPHAGIA 61 0.0024
362 BLOOD CHOLESTEROL ABNORMAL 11 0.0024
363 MUSCLE ATROPHY 30 0.0024
364 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 123 0.0024
365 LIGAMENT SPRAIN 23 0.0023
366 TRISMUS 12 0.0023
367 THERAPY NON-RESPONDER 104 0.0023
368 HEART RATE DECREASED 81 0.0023
369 ARTHROPATHY 128 0.0023
370 HYPERTHYROIDISM 33 0.0023
371 CHOKING 44 0.0023
372 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
373 INSOMNIA 598 0.0022
374 RENAL TUBULAR NECROSIS 22 0.0022
375 KNEE OPERATION 22 0.0022
376 RIB FRACTURE 46 0.0022
377 ACUTE RESPIRATORY FAILURE 43 0.0022
378 OVERWEIGHT 12 0.0022
379 MYASTHENIA GRAVIS 18 0.0022
380 NIGHTMARE 77 0.0022
381 INFUSION SITE SWELLING 14 0.0022
382 CONSTIPATION 485 0.0022
383 MUSCULOSKELETAL DISORDER 42 0.0022
384 PULMONARY THROMBOSIS 24 0.0022
385 URINARY TRACT INFECTION 375 0.0022
386 SARS-COV-2 TEST POSITIVE 29 0.0022
387 BRAIN INJURY 22 0.0022
388 WITHDRAWAL SYNDROME 92 0.0022
389 JOINT DISLOCATION 23 0.0022
390 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
391 UNEVALUABLE EVENT 163 0.0022
392 FEELING DRUNK 16 0.0022
393 DISTURBANCE IN ATTENTION 116 0.0021
394 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
395 RENAL CYST 17 0.0021
396 LIMB INJURY 58 0.0021
397 DEVICE ISSUE 191 0.0021
398 THERAPEUTIC RESPONSE UNEXPECTED 95 0.0021
399 CORONAVIRUS INFECTION 14 0.0021
400 THERMAL BURN 15 0.0021
401 BLOOD PRESSURE ABNORMAL 42 0.0021
402 INFLAMMATION 109 0.0021
403 WOUND INFECTION 23 0.0021
404 WHEEZING 124 0.0021
405 POST PROCEDURAL INFECTION 17 0.0021
406 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
407 BLOOD MAGNESIUM DECREASED 18 0.0021
408 WOUND 58 0.0021
409 EATING DISORDER 44 0.0021
410 STRESS CARDIOMYOPATHY 12 0.0021
411 FAECES SOFT 15 0.0021
412 DIZZINESS POSTURAL 20 0.0021
413 IMPAIRED GASTRIC EMPTYING 28 0.0021
414 ABNORMAL LOSS OF WEIGHT 14 0.0021
415 CONTRAINDICATED PRODUCT ADMINISTERED 62 0.0020
416 BRUXISM 11 0.0020
417 POST PROCEDURAL COMPLICATION 39 0.0020
418 HYPOPHOSPHATAEMIA 15 0.0020
419 HYPERSOMNIA 58 0.0020
420 ANAL INCONTINENCE 18 0.0020
421 SENSORY LOSS 16 0.0020
422 FULL BLOOD COUNT ABNORMAL 21 0.0020
423 FEEDING DISORDER 40 0.0020
424 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
425 GOUT 35 0.0019
426 VITAMIN D DEFICIENCY 19 0.0019
427 SCIATICA 31 0.0019
428 PRODUCT PRESCRIBING ERROR 46 0.0019
429 BLOOD POTASSIUM DECREASED 58 0.0019
430 TRANSIENT ISCHAEMIC ATTACK 65 0.0019
431 GASTROOESOPHAGEAL REFLUX DISEASE 155 0.0019
432 APHASIA 58 0.0019
433 DYSPHAGIA 182 0.0019
434 CYSTITIS 61 0.0019
435 HYPERTENSION 402 0.0019
436 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
437 FIBROMYALGIA 46 0.0019
438 JOINT SWELLING 228 0.0019
439 MENTAL DISORDER 82 0.0019
440 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
441 PLEURAL EFFUSION 114 0.0019
442 CELLULITIS 94 0.0019
443 MUSCULAR WEAKNESS 211 0.0019
444 DEPRESSION 422 0.0019
445 OXYGEN SATURATION DECREASED 104 0.0018
446 AMNESIA 120 0.0018
447 UROSEPSIS 17 0.0018
448 HAND FRACTURE 13 0.0018
449 ANXIETY 520 0.0018
450 HEPATIC STEATOSIS 34 0.0018
451 HOSPICE CARE 18 0.0018
452 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
453 CRYING 66 0.0018
454 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
455 BLADDER DISORDER 18 0.0018
456 MUSCULOSKELETAL CHEST PAIN 28 0.0018
457 PANIC REACTION 13 0.0018
458 COORDINATION ABNORMAL 25 0.0018
459 EMPHYSEMA 18 0.0018
460 HAEMATOMA 46 0.0018
461 ULCER HAEMORRHAGE 12 0.0018
462 SEROTONIN SYNDROME 34 0.0018
463 DISABILITY 35 0.0018
464 UNDERDOSE 129 0.0018
465 DECREASED ACTIVITY 19 0.0018
466 PRESCRIBED OVERDOSE 34 0.0018
467 UPPER LIMB FRACTURE 35 0.0018
468 LYMPHOCYTE COUNT DECREASED 31 0.0018
469 SCAB 20 0.0018
470 ASTHMA 198 0.0018
471 PSEUDOMONAS INFECTION 15 0.0017
472 CARDIOGENIC SHOCK 25 0.0017
473 URINARY RETENTION 58 0.0017
474 MYOPATHY 15 0.0017
475 HYSTERECTOMY 15 0.0017
476 BURSITIS 21 0.0017
477 BLOOD PRESSURE DECREASED 114 0.0017
478 SKIN LESION 47 0.0017
479 RIGHT VENTRICULAR FAILURE 12 0.0017
480 FLUID RETENTION 87 0.0017
481 SPINAL OSTEOARTHRITIS 15 0.0017
482 HIP ARTHROPLASTY 26 0.0017
483 SEASONAL ALLERGY 24 0.0017
484 FEELING COLD 47 0.0017
485 NODULE 22 0.0017
486 INTENTIONAL SELF-INJURY 34 0.0017
487 PULMONARY HYPERTENSION 35 0.0017
488 DRUG INTOLERANCE 162 0.0017
489 DRY MOUTH 136 0.0017
490 DRY THROAT 17 0.0017
491 CONTUSION 161 0.0017
492 SLUGGISHNESS 17 0.0017
493 HYPOTENSION 334 0.0017
494 MULTIPLE SCLEROSIS RELAPSE 114 0.0017
495 ACUTE KIDNEY INJURY 254 0.0017
496 MYOCARDITIS 19 0.0017
497 MUSCLE TWITCHING 38 0.0016
498 INTENTIONAL DOSE OMISSION 47 0.0016
499 TREATMENT NONCOMPLIANCE 90 0.0016
500 COUGH 459 0.0016
501 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
502 SKIN REACTION 23 0.0016
503 ATRIAL FLUTTER 13 0.0016
504 PETECHIAE 17 0.0016
505 HEPATIC ENZYME INCREASED 111 0.0016
506 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
507 CARDIOMYOPATHY 24 0.0016
508 MIOSIS 13 0.0016
509 DYSPNOEA EXERTIONAL 61 0.0016
510 MUSCLE STRAIN 14 0.0016
511 TACHYPNOEA 22 0.0016
512 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
513 HYPOAESTHESIA 242 0.0016
514 KNEE ARTHROPLASTY 34 0.0016
515 PNEUMONIA 521 0.0016
516 DYSPHONIA 94 0.0016
517 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
518 PERIPHERAL COLDNESS 22 0.0016
519 ROAD TRAFFIC ACCIDENT 67 0.0016
520 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
521 BEDRIDDEN 21 0.0016
522 RHEUMATOID ARTHRITIS 181 0.0016
523 EMOTIONAL DISORDER 49 0.0016
524 SPINAL DISORDER 15 0.0016
525 IMPAIRED HEALING 52 0.0016
526 POISONING DELIBERATE 15 0.0016
527 ASPARTATE AMINOTRANSFERASE INCREASED 84 0.0016
528 DIZZINESS 787 0.0016
529 AORTIC ANEURYSM 12 0.0016
530 MUSCLE SPASMS 288 0.0016
531 QUALITY OF LIFE DECREASED 21 0.0016
532 AGEUSIA 39 0.0016
533 BACK INJURY 17 0.0016
534 PRODUCT DOSE OMISSION IN ERROR 44 0.0016
535 ATRIOVENTRICULAR BLOCK 12 0.0016
536 RASH PRURITIC 84 0.0015
537 ANAEMIA 295 0.0015
538 INJECTION SITE NODULE 17 0.0015
539 CARDIOMEGALY 19 0.0015
540 TOOTH FRACTURE 17 0.0015
541 ASTHENIA 579 0.0015
542 TENDON RUPTURE 19 0.0015
543 ABASIA 38 0.0015
544 INADEQUATE ANALGESIA 13 0.0015
545 DERMATITIS 32 0.0015
546 AFFECTIVE DISORDER 12 0.0015
547 ADVERSE DRUG REACTION 137 0.0015
548 HEAD DISCOMFORT 27 0.0015
549 ABDOMINAL PAIN 353 0.0015
550 BRONCHITIS 112 0.0015
551 RENAL PAIN 16 0.0015
552 OBESITY 24 0.0015
553 CYTOMEGALOVIRUS INFECTION 25 0.0015
554 MASS 21 0.0015
555 WEIGHT DECREASED 419 0.0015
556 SPINAL FRACTURE 30 0.0015
557 IMPAIRED DRIVING ABILITY 17 0.0015
558 PHARYNGEAL OEDEMA 23 0.0015
559 PAIN IN EXTREMITY 438 0.0015
560 SKIN CANCER 32 0.0015
561 HEPATITIS 38 0.0015
562 PANIC ATTACK 54 0.0015
563 THERAPY CESSATION 76 0.0015
564 RENAL FAILURE 196 0.0015
565 INFUSION SITE PAIN 19 0.0015
566 UNRESPONSIVE TO STIMULI 38 0.0015
567 FEELING ABNORMAL 352 0.0015
568 THERAPEUTIC RESPONSE DECREASED 89 0.0015
569 HYPERHIDROSIS 189 0.0015
570 MADAROSIS 17 0.0015
571 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
572 RETCHING 31 0.0015
573 DEAFNESS 38 0.0015
574 CYST 18 0.0014
575 GASTROINTESTINAL INFECTION 13 0.0014
576 ANHEDONIA 38 0.0014
577 FATIGUE 1123 0.0014
578 EOSINOPHIL COUNT INCREASED 12 0.0014
579 PRESYNCOPE 35 0.0014
580 INTENTIONAL PRODUCT USE ISSUE 126 0.0014
581 BACK PAIN 334 0.0014
582 NECK PAIN 80 0.0014
583 CHOLECYSTITIS 17 0.0014
584 THROAT IRRITATION 64 0.0014
585 PRODUCTIVE COUGH 68 0.0014
586 BRAIN NEOPLASM 13 0.0014
587 IRON DEFICIENCY ANAEMIA 13 0.0014
588 VITAMIN D DECREASED 12 0.0014
589 HYPOGLYCAEMIA 68 0.0014
590 SEPSIS 156 0.0014
591 LOSS OF CONSCIOUSNESS 179 0.0014
592 HERNIA 27 0.0014
593 HYPOACUSIS 60 0.0014
594 AKATHISIA 19 0.0014
595 PERICARDIAL EFFUSION 32 0.0014
596 SKIN SWELLING 12 0.0014
597 PAIN 846 0.0014
598 ELECTROLYTE IMBALANCE 16 0.0014
599 GENERALISED OEDEMA 17 0.0014
600 EUPHORIC MOOD 14 0.0014
601 SURGERY 80 0.0014
602 FEELING JITTERY 26 0.0014
603 STAPHYLOCOCCAL INFECTION 45 0.0014
604 IRRITABILITY 82 0.0014
605 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
606 SECRETION DISCHARGE 17 0.0014
607 RESPIRATORY RATE INCREASED 12 0.0014
608 AFFECT LABILITY 13 0.0013
609 LUNG DISORDER 66 0.0013
610 METABOLIC ACIDOSIS 43 0.0013
611 MALIGNANT MELANOMA 18 0.0013
612 BACTERIAL INFECTION 25 0.0013
613 HYPERLIPIDAEMIA 16 0.0013
614 OCULAR DISCOMFORT 15 0.0013
615 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
616 HEPATIC CIRRHOSIS 25 0.0013
617 NEPHROLITHIASIS 61 0.0013
618 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
619 STATUS EPILEPTICUS 15 0.0013
620 BLOOD SODIUM DECREASED 25 0.0013
621 RESPIRATORY TRACT CONGESTION 21 0.0013
622 VISUAL IMPAIRMENT 163 0.0013
623 PRODUCT DOSE OMISSION ISSUE 385 0.0013
624 COLD SWEAT 23 0.0013
625 ENCEPHALOPATHY 32 0.0013
626 CANDIDA INFECTION 22 0.0013
627 FEAR 35 0.0013
628 DRUG WITHDRAWAL SYNDROME 114 0.0013
629 UNINTENTIONAL MEDICAL DEVICE REMOVAL 15 0.0013
630 MENTAL STATUS CHANGES 36 0.0013
631 ARTHRALGIA 538 0.0013
632 DYSPNOEA 732 0.0013
633 CIRCULATORY COLLAPSE 22 0.0013
634 FAECES DISCOLOURED 28 0.0013
635 RESPIRATORY FAILURE 94 0.0013
636 PRODUCT SUBSTITUTION ISSUE 74 0.0013
637 MOOD ALTERED 35 0.0013
638 TREATMENT FAILURE 106 0.0013
639 EYELID PTOSIS 13 0.0013
640 MUSCULOSKELETAL DISCOMFORT 22 0.0013
641 WEIGHT INCREASED 285 0.0013
642 GASTROINTESTINAL DISORDER 114 0.0013
643 PRODUCT USE COMPLAINT 20 0.0013
644 RESPIRATORY TRACT INFECTION 33 0.0013
645 ACCIDENTAL OVERDOSE 46 0.0013
646 ACCIDENT 15 0.0013
647 BLOOD PRESSURE INCREASED 192 0.0013
648 MULTIPLE SCLEROSIS 60 0.0013
649 TYPE 2 DIABETES MELLITUS 42 0.0012
650 SEIZURE 144 0.0012
651 CARDIAC FAILURE 100 0.0012
652 RENAL INJURY 37 0.0012
653 FLUID OVERLOAD 18 0.0012
654 HERPES ZOSTER 71 0.0012
655 INTERNAL HAEMORRHAGE 14 0.0012
656 PRODUCT USE ISSUE 230 0.0012
657 MUSCULOSKELETAL PAIN 64 0.0012
658 THERAPY CHANGE 12 0.0012
659 CHOLELITHIASIS 40 0.0012
660 HAEMATOCHEZIA 67 0.0012
661 HAEMATOCRIT DECREASED 24 0.0012
662 INABILITY TO AFFORD MEDICATION 12 0.0012
663 NASAL CONGESTION 71 0.0012
664 SYNCOPE 120 0.0012
665 RHABDOMYOLYSIS 50 0.0012
666 SINUS TACHYCARDIA 17 0.0012
667 DERMATITIS ALLERGIC 15 0.0012
668 ABSCESS 19 0.0012
669 NERVOUSNESS 62 0.0012
670 OSTEOPENIA 18 0.0012
671 HEMIPARESIS 20 0.0012
672 SINUSITIS 121 0.0012
673 BACTERAEMIA 14 0.0012
674 SEPTIC SHOCK 51 0.0012
675 DECREASED APPETITE 272 0.0012
676 HEART RATE INCREASED 116 0.0012
677 NERVE INJURY 13 0.0012
678 HYPOTHYROIDISM 37 0.0012
679 INTENTIONAL PRODUCT MISUSE 101 0.0012
680 BONE DISORDER 21 0.0012
681 VERTIGO 70 0.0011
682 JOINT STIFFNESS 30 0.0011
683 GLAUCOMA 22 0.0011
684 HYPERKALAEMIA 40 0.0011
685 DEHYDRATION 151 0.0011
686 SWELLING 105 0.0011
687 ECONOMIC PROBLEM 17 0.0011
688 SENSORY DISTURBANCE 18 0.0011
689 KIDNEY INFECTION 22 0.0011
690 NAUSEA 886 0.0011
691 RENAL IMPAIRMENT 94 0.0011
692 PARAESTHESIA 176 0.0011
693 JOINT RANGE OF MOTION DECREASED 15 0.0011
694 BODY TEMPERATURE DECREASED 11 0.0011
695 PULMONARY EMBOLISM 106 0.0011
696 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
697 COVID-19 195 0.0011
698 SKIN DISCOLOURATION 51 0.0011
699 ABDOMINAL DISCOMFORT 186 0.0011
700 PHARYNGITIS STREPTOCOCCAL 12 0.0011
701 PSORIATIC ARTHROPATHY 45 0.0011
702 HAEMATEMESIS 28 0.0011
703 DRUG INEFFECTIVE 1455 0.0011
704 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
705 DRUG PRESCRIBING ERROR 21 0.0011
706 PRODUCT PHYSICAL ISSUE 22 0.0011
707 PRODUCT ADMINISTRATION ERROR 22 0.0011
708 INTESTINAL OBSTRUCTION 41 0.0011
709 DENTAL CARIES 12 0.0011
710 COMPLETED SUICIDE 90 0.0011
711 ABDOMINAL PAIN UPPER 222 0.0011
712 LETHARGY 62 0.0011
713 HYPOMAGNESAEMIA 15 0.0011
714 FLATULENCE 61 0.0011
715 CATARACT 64 0.0011
716 HOSPITALISATION 165 0.0011
717 MALNUTRITION 12 0.0011
718 PRODUCT DOSE OMISSION 70 0.0011
719 OEDEMA 58 0.0011
720 SINUS DISORDER 21 0.0011
721 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
722 ATRIAL FIBRILLATION 103 0.0011
723 INFECTION 153 0.0011
724 FRACTURE 20 0.0011
725 SMALL INTESTINAL OBSTRUCTION 13 0.0011
726 ABDOMINAL DISTENSION 110 0.0011
727 NASOPHARYNGITIS 194 0.0011
728 SCAR 18 0.0011
729 RESPIRATORY DISTRESS 29 0.0010
730 FUNGAL INFECTION 35 0.0010
731 MUSCLE TIGHTNESS 17 0.0010
732 INSURANCE ISSUE 16 0.0010
733 DRUG EFFECT INCOMPLETE 38 0.0010
734 PROCEDURAL PAIN 29 0.0010
735 GASTRIC HAEMORRHAGE 12 0.0010
736 THYROID DISORDER 16 0.0010
737 THROAT TIGHTNESS 28 0.0010
738 ANKLE FRACTURE 16 0.0010
739 BODY HEIGHT DECREASED 11 0.0010
740 SNEEZING 23 0.0010
741 SWOLLEN TONGUE 32 0.0010
742 SPINAL PAIN 12 0.0010
743 SEXUAL DYSFUNCTION 12 0.0010
744 INFLUENZA 114 0.0010
745 ILLNESS 105 0.0010
746 CARDIAC DISORDER 95 0.0010
747 MYDRIASIS 13 0.0010
748 MALAISE 444 0.0010
749 DEVICE DIFFICULT TO USE 67 0.0010
750 PRODUCT USE IN UNAPPROVED INDICATION 250 0.0010
751 HEADACHE 631 0.0010
752 MOOD SWINGS 32 0.0010
753 FEMUR FRACTURE 31 0.0010
754 OSTEOMYELITIS 18 0.0010
755 VOMITING 467 0.0010
756 DRUG EFFECT DECREASED 53 0.0010
757 BRONCHOSPASM 14 0.0010
758 BODY TEMPERATURE INCREASED 20 0.0010
759 RED BLOOD CELL COUNT DECREASED 28 0.0010
760 BLISTER 55 0.0010
761 TACHYCARDIA 87 0.0010
762 DIVERTICULITIS 27 0.0010
763 HAIR TEXTURE ABNORMAL 13 0.0010
764 NEUROPATHY PERIPHERAL 92 0.0010
765 ANOSMIA 14 0.0010
766 ILEUS 12 0.0010
767 BLOOD UREA INCREASED 16 0.0010
768 HAEMOGLOBIN DECREASED 98 0.0010
769 THERAPY INTERRUPTED 68 0.0010
770 INTENTIONAL OVERDOSE 61 0.0010
771 CHEST DISCOMFORT 97 0.0009
772 RENAL DISORDER 44 0.0009
773 RASH MACULO-PAPULAR 21 0.0009
774 EYE DISORDER 31 0.0009
775 MYALGIA 160 0.0009
776 LEUKOCYTOSIS 17 0.0009
777 IMMUNODEFICIENCY 14 0.0009
778 ERYTHEMA 193 0.0009
779 APHONIA 13 0.0009
780 DIABETES MELLITUS 71 0.0009
781 HEART RATE IRREGULAR 21 0.0009
782 EAR PAIN 18 0.0009
783 CORONARY ARTERY DISEASE 28 0.0009
784 OSTEOPOROSIS 38 0.0009
785 PULMONARY OEDEMA 41 0.0009
786 FEELING HOT 56 0.0009
787 ABDOMINAL PAIN LOWER 23 0.0009
788 SUBDURAL HAEMATOMA 13 0.0009
789 OFF LABEL USE 794 0.0009
790 DRY EYE 45 0.0009
791 ADVERSE EVENT 83 0.0009
792 TOOTH DISORDER 20 0.0009
793 DEVICE LEAKAGE 39 0.0009
794 DYSURIA 33 0.0009
795 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
796 TASTE DISORDER 18 0.0009
797 LOWER LIMB FRACTURE 17 0.0009
798 CARDIAC FAILURE CONGESTIVE 71 0.0009
799 PALLOR 24 0.0009
800 ACUTE MYOCARDIAL INFARCTION 26 0.0009
801 SKIN HAEMORRHAGE 13 0.0009
802 ALOPECIA 172 0.0009
803 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
804 HAEMORRHOIDS 17 0.0009
805 CARDIOVASCULAR DISORDER 22 0.0009
806 EXTRA DOSE ADMINISTERED 35 0.0009
807 DYSPEPSIA 85 0.0009
808 MELAENA 19 0.0009
809 HYPOAESTHESIA ORAL 13 0.0009
810 DEVICE BREAKAGE 35 0.0009
811 HYPERSENSITIVITY 160 0.0009
812 LIVER FUNCTION TEST ABNORMAL 25 0.0009
813 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
814 CHEST PAIN 158 0.0009
815 DRUG LEVEL INCREASED 14 0.0008
816 SKIN DISORDER 28 0.0008
817 PARALYSIS 12 0.0008
818 NIGHT SWEATS 27 0.0008
819 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 151 0.0008
820 ANGINA PECTORIS 24 0.0008
821 GASTRITIS 22 0.0008
822 BLINDNESS 34 0.0008
823 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
824 ANGER 28 0.0008
825 SKIN FISSURES 16 0.0008
826 TOXICITY TO VARIOUS AGENTS 138 0.0008
827 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
828 CHILLS 95 0.0008
829 MOUTH ULCERATION 17 0.0008
830 DEPENDENCE 44 0.0008
831 VISION BLURRED 110 0.0008
832 NERVOUS SYSTEM DISORDER 25 0.0008
833 NEUROTOXICITY 14 0.0008
834 DRUG-INDUCED LIVER INJURY 25 0.0008
835 MIGRAINE 76 0.0008
836 IMPAIRED WORK ABILITY 17 0.0008
837 COLITIS 30 0.0008
838 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
839 ISCHAEMIC STROKE 14 0.0008
840 GALLBLADDER DISORDER 14 0.0008
841 INJECTION SITE MASS 29 0.0008
842 DIARRHOEA 506 0.0008
843 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
844 PAIN IN JAW 22 0.0008
845 RASH MACULAR 27 0.0008
846 PYREXIA 267 0.0008
847 GASTRIC DISORDER 26 0.0008
848 DRUG ABUSE 63 0.0008
849 COMA 36 0.0008
850 AGRANULOCYTOSIS 14 0.0008
851 EXPIRED PRODUCT ADMINISTERED 25 0.0008
852 THROMBOCYTOPENIA 84 0.0008
853 THROMBOSIS 60 0.0007
854 BURNING SENSATION 52 0.0007
855 PRURITUS 284 0.0007
856 PRODUCT DISPENSING ERROR 16 0.0007
857 PRODUCT PRESCRIBING ISSUE 16 0.0007
858 PALPITATIONS 86 0.0007
859 CEREBROVASCULAR ACCIDENT 124 0.0007
860 INJECTION SITE PRURITUS 49 0.0007
861 LACRIMATION INCREASED 22 0.0007
862 EXTRAPYRAMIDAL DISORDER 18 0.0007
863 DEATH 622 0.0007
864 DISCOMFORT 44 0.0007
865 EPILEPSY 22 0.0007
866 BONE PAIN 42 0.0007
867 DEVICE RELATED INFECTION 11 0.0007
868 EAR INFECTION 19 0.0007
869 OROPHARYNGEAL PAIN 66 0.0007
870 RHINORRHOEA 46 0.0007
871 CHROMATURIA 16 0.0007
872 FREQUENT BOWEL MOVEMENTS 19 0.0007
873 LIVER DISORDER 31 0.0007
874 RASH 304 0.0007
875 PSORIASIS 91 0.0007
876 CEREBRAL INFARCTION 17 0.0007
877 CARDIO-RESPIRATORY ARREST 29 0.0007
878 LIP SWELLING 23 0.0007
879 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
880 LYMPHADENOPATHY 24 0.0007
881 BLOOD POTASSIUM INCREASED 11 0.0007
882 PERITONITIS 14 0.0007
883 TOOTH LOSS 14 0.0007
884 RECTAL HAEMORRHAGE 29 0.0007
885 ILL-DEFINED DISORDER 41 0.0007
886 DISEASE RECURRENCE 32 0.0007
887 ACNE 51 0.0007
888 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 136 0.0007
889 EMOTIONAL DISTRESS 81 0.0007
890 PANCREATITIS ACUTE 15 0.0007
891 CARDIAC ARREST 55 0.0007
892 GASTROENTERITIS VIRAL 12 0.0007
893 APPLICATION SITE PRURITUS 15 0.0007
894 HAEMORRHAGE 69 0.0007
895 LEUKOPENIA 33 0.0007
896 PRURITUS GENERALISED 14 0.0006
897 OSTEONECROSIS OF JAW 16 0.0006
898 ASCITES 19 0.0006
899 CEREBRAL HAEMORRHAGE 23 0.0006
900 BLOOD URINE PRESENT 12 0.0006
901 TINNITUS 29 0.0006
902 NEOPLASM MALIGNANT 42 0.0006
903 BLOOD GLUCOSE DECREASED 30 0.0006
904 DEVICE DELIVERY SYSTEM ISSUE 17 0.0006
905 RESPIRATORY ARREST 17 0.0006
906 RESPIRATORY DISORDER 18 0.0006
907 OVERDOSE 129 0.0006
908 DRUG DOSE OMISSION 98 0.0006
909 DISEASE PROGRESSION 70 0.0006
910 ARRHYTHMIA 28 0.0006
911 EPISTAXIS 44 0.0006
912 LACTIC ACIDOSIS 19 0.0006
913 PRODUCT PREPARATION ERROR 12 0.0006
914 SWELLING FACE 38 0.0006
915 INJECTION SITE WARMTH 12 0.0006
916 MYOCARDIAL INFARCTION 101 0.0006
917 FOETAL EXPOSURE DURING PREGNANCY 47 0.0006
918 DEVICE USE ERROR 20 0.0006
919 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
920 PANCREATITIS 30 0.0006
921 EYE PAIN 32 0.0006
922 HYPOKALAEMIA 26 0.0006
923 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
924 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
925 BLOOD BILIRUBIN INCREASED 15 0.0006
926 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
927 DYSGEUSIA 40 0.0005
928 BLOOD CHOLESTEROL INCREASED 25 0.0005
929 TARDIVE DYSKINESIA 15 0.0005
930 HOT FLUSH 40 0.0005
931 HEPATIC FAILURE 16 0.0005
932 ECZEMA 27 0.0005
933 INCORRECT DOSE ADMINISTERED 117 0.0005
934 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 23 0.0005
935 INFLUENZA LIKE ILLNESS 40 0.0005
936 EYE SWELLING 18 0.0005
937 INJURY 34 0.0005
938 VIRAL INFECTION 16 0.0005
939 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
940 STOMATITIS 29 0.0005
941 INJECTION SITE ERYTHEMA 59 0.0005
942 COLITIS ULCERATIVE 21 0.0005
943 EYE IRRITATION 27 0.0005
944 DRUG RESISTANCE 12 0.0005
945 DRUG ADMINISTRATION ERROR 14 0.0005
946 JAUNDICE 12 0.0004
947 INJECTION SITE SWELLING 34 0.0004
948 FLUSHING 45 0.0004
949 URTICARIA 74 0.0004
950 PNEUMONITIS 12 0.0004
951 HYPERGLYCAEMIA 16 0.0004
952 HAEMATURIA 15 0.0004
953 HEPATIC FUNCTION ABNORMAL 16 0.0004
954 APPLICATION SITE ERYTHEMA 11 0.0004
955 ANAPHYLACTIC REACTION 23 0.0004
956 SKIN EXFOLIATION 35 0.0004
957 INJECTION SITE BRUISING 33 0.0004
958 PRODUCT QUALITY ISSUE 55 0.0004
959 INJECTION SITE HAEMORRHAGE 32 0.0004
960 OCULAR HYPERAEMIA 19 0.0004
961 DEVICE MALFUNCTION 28 0.0004
962 VISUAL ACUITY REDUCED 13 0.0004
963 EXPOSURE DURING PREGNANCY 24 0.0004
964 PLASMA CELL MYELOMA 15 0.0004
965 BLOOD GLUCOSE INCREASED 72 0.0004
966 RENAL FAILURE ACUTE 16 0.0004
967 RASH ERYTHEMATOUS 18 0.0004
968 OSTEONECROSIS 12 0.0004
969 PRODUCT ADHESION ISSUE 13 0.0004
970 DRY SKIN 47 0.0004
971 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
972 SKIN BURNING SENSATION 23 0.0003
973 INJECTION SITE REACTION 22 0.0003
974 INJECTION SITE PAIN 98 0.0003
975 ANGIOEDEMA 14 0.0003
976 INTERSTITIAL LUNG DISEASE 15 0.0003
977 DEEP VEIN THROMBOSIS 20 0.0003
978 DRUG DEPENDENCE 48 0.0003
979 LUNG NEOPLASM MALIGNANT 12 0.0003
980 NEUTROPENIA 39 0.0003
981 PROSTATE CANCER 22 0.0003
982 PLATELET COUNT DECREASED 29 0.0003
983 DERMATITIS ATOPIC 14 0.0003
984 PANCYTOPENIA 14 0.0003
985 DEVICE EXPULSION 16 0.0002
986 FEBRILE NEUTROPENIA 16 0.0002
987 NO ADVERSE EVENT 40 0.0002
988 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
989 BREAST CANCER 15 0.0002
990 PRODUCT STORAGE ERROR 14 0.0002
991 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001